Problematic issues related to screening for diabetic retinopathy

Czech version

Authors: P. Skalická; B. Kalvodová
Authors‘ workplace: Oční klinika 1. lékařské fakulty UK a VFN Praha, přednostka doc. MUDr. Bohdana Kalvodová, CSc.
Published in: Vnitř Lék 2013; 59(3): 218-223
Category: Case Reports

Overview

The aim of this paper is to highlight the importance of screening for diabetic retinopathy and the education of diabetic patients. The key prerequisite of an effective screening is close collaboration between health care professionals. Successful screening detects DR at early stages and helps to prevent severe visual loss. Two cases of proliferative DR exhibiting the most serious complications (vitreous haemorrhage, traction retinal detachment and combined traction and rhegmatogenous retinal detachment, neovascular glaucoma) are reported. The first comorbid patient lost her vision despite the adequate treatment. The second patient was successfully managed with pars plana vitrectomy with final visual acuity better to the preoperative value.

Key words:
diabetic retinopathy – screening – indirect biomicroscopy

Sources

1. Kalvodová B. Screening diabetické retinopatie v ČR – guideline. Čes slov Oftal 2002; 58: 3–10.

2. Sosna T. et al. Diabetická retinopatie – rizikové faktory, prevence a terapie. Čes slov Oftal 2010; 66: 195–203.

3. Kalvodová B et al. Diagnostika a léčba diabetické retinopatie a jejích komplikací. DMEV Diabetologie 2002; 5: 214–218.

4. Standardy pro diagnostiku a léčbu diabetické retinopatie a jejích komplikací. DMEV Diabetologie 2004; 7: 22–25.

5. Ústav zdravotnických informací a statistiky ČR. Péče o nemocné s cukrovkou 2011: 8.

6. Zhang X et al. Prevalence of diabetic retinopathy in the United States, 2005–2008. JAMA 2010; 304: 649–656.

Labels

Diabetology Endocrinology Internal medicine

What has the largest study in the history of diabetology brought us?

Changes in weight and diabetes compensation (HbA1c) in patients with diabetes mellitus type 2 after adding exenatide (Byetta) to the current treatment in 28 diabetology departments in the Czech Republic – BIBY-I study (observations lasting 3 to 12 months)

Patophysiology of diabetic retinopathy

Risk factors for diabetic retinopathy

Present state of diagnostic and screening of the diabetic retinopathy and diabetic macular oedema

The benefit of pars plana vitrectomy for the resolution of complications of proliferative diabetic retinopathy

Treatment of diabetic macular oedema

Diabetic nephropathy/diabetic kidney disease

Incretin therapy and diabetic retinopathy

Present and future of insulin treatment

Diabetic retinopathy in the Czech National Diabetes Programme 2012–2022

Progression of diabetic retinopathy in pregnancy

Diabetic macular oedema in the third trimester of pregnancy

Treatment of diabetic macular oedema in a type 1 diabetes patient – mistakes in interdisciplinary collaboration

Article was published in

Internal Medicine

2013 Issue 3